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Abstract: 
In this work the cold extraction process was done with the help of methanol. About 200gms of powdered material 
was taken in a clean, flat bottomed glass container and soaked in 750 ml of methanol. The container with its 
contents were sealed and kept for period of 7 days accompanied by continuous shaking with the shaker. The whole 
mixture then went under a coarse filtration by a piece of a clean, white cotton wool.Investigation revealed the 
presence of Alkaloid, Tannin, Saponin, Phenol in Methanolic Extract of Tephrosia purpurea  while only Phenol 
were present in Phenolic Extract of Tephrosia purpurea The results of the study clearly indicate that METP Extract 
and PETP Extract at a dose of 500 mg/kg & 400 mg/kg significantly lowered serum lipid levels (P<0.01). PETP 
Extract at a dose of 500 mg/kg significantly lowered serum lipid  levels, (P<0.001) i.e. antihyperlipidemic activity 
which was found to be more effective in higher dose of PETP as compared to METP and lower dose of PETP when 
administered orally in triton induced hyperlipidemic models.The results concluded that PETP (500 mg/kg) have 
definite antihyperlipidemic activity in Triton X-100 induced hyperlipidemic model and which is equipotent activity 
when compared with Atorvastatin treated groups. Further studies on this extract may lead to identify the possible 
mechanism of action and isolation of active principle from the same. 
Keywords: Tephrosia purpurea, Antihyperlipidemic activity  
Corresponding author: 
Jagadeeshwar.K, 
Assistant Professor,  
Department of Pharmacology,  
Janagaon Institute of Pharmaceutical Sciences,  
Janagaon, Telangana, India 
Email ID: jagadeeshwarkolguri@gmail.com  
 
Please cite this article in press as Jagadeeshwar.K  and P. Sravan Kumar, Evalaution of Antihyperlipidemic 
Activity of Tephrosia Purpurea Plant Extracts In Mice, Indo Am. J. P. Sci, 2017; 4[05]. 
 
 
 
QR code 
 
IAJPS 2017, 4 (05), 1377-1383      Jagadeeshwar.K and P. Sravan Kumar    ISSN 2349-7750 
 w w w . i a j p s . c o m  
 
Page 1378 
 
INTRODUCTION: 
Lipid is the scientific term for fats in the blood. At 
Normal levels, lipids perform important functions in 
your body, but can cause health problems if they are 
present in excess. The term hyperlipidemia means 
high lipid levels. Hyperlipidemia includes several 
conditions, but it usually means that you have high 
cholesterol and high triglyceride levels[1-5]. 
The pathophysiology of hyperlipidemia can be 
studied under two headins, i.e., primary 
hyperlipidemia and secondary hyperlipidemia. The 
pathophysiology of primary hyperlipidemia involve 
that the idiopathic hyperchylomicronemia defect in 
lipid metabolism leads to hypertriglyceridemia and 
hyperchylomicronemia which is caused by a defect in 
lipoprotein lipase activity or the absence of the 
surface apoprotein CII.Moreover, 
hyperchylomicronemia in cats with autosomal 
recessive defect in lipoprotein lipase (LPL) activity 
showed the occurrence of primary hyperlipidemia[6-
9] . 
In secondary hyperlipidemia, the postprandial 
absorption of chylomicrons from the gastrointestinal 
tract occurs 30- 60 min after ingestion of a meal 
containing fat that may increase serum triglycerides 
for 3-10 hours.The diabetes mellitus patients have 
been noted to possess low LPL activity which further 
caused high synthesis of VLDL cholesterol by the 
liver ultimately leading to hyperlipidemia. Moreover, 
hypothyroidism-induced low LPL activity and 
lipolytic activity has been noted to reduce hepatic 
degradation of cholesterol to bile acids. Furthermore, 
hyperadrenocorticism increased the synthesis of 
VLDL by the liver causing both 
hypercholesterolemia and hypertriglyceridemia.[10-
15] Liverdisease hypercholesterolemia has been 
noted to be caused by reduced excretion of 
cholesterol in the bile. Furthermore, in nephrotic 
syndrome, the common synthetic pathway for 
albumin and cholesterol causes low oncotic pressure 
ultimately leading to enhanced cholesterol 
synthesis[15-17]. 
The mainstay of treatment for hyperlipidemia is 
dietary and lifestyle modification, followed by drug 
therapy, as necessary. Hyperlipidemia should not be 
considered refractory to dietary treatment if the 
therapeutic regimen included animal products or 
more than minimal amounts of vegetable oils. Such 
diets do not lower LDL cholesterol concentrations as 
effectively as high-fiber, low-fat diets that exclude 
animal products[18-20].. 
 
 
Regular exercise can improve lipid concentrations. 
Low to moderate amounts of physical activity such as  
walking lower triglyceride concentrations by an 
average of 10 mg/dL, while raising HDL by 5 mg/dL  
(these numbers are means drawn from large groups). 
More strenuous activity may have greater effects. 
Patients with familial hypercholesterolemia typically 
require medications starting in early childhood. 
Major complications of hyperlipidemia are 
atherosclerotic heart disease, heart attack and heart 
stroke, but atherosclerosis is primary cause of death. 
Developing countries are reliant on medicinal plants 
as their main source of treatment for diseases. As 
Tephrosia purpurea have the native habitat the 
production is more so it is locally available cost 
effective with no side effects.As Tephrosia purpurea 
is cost effective and beneficiary in metabolism of 
cholesterol, so it has been taken in to consideration in 
order “To evaluate Anti-hyperlipidemic activity of 
Methanolic Extract and Phenolic Extracts of 
Tephrosia purpurea  in triton X -100 induced 
hyperlipidemic mice”. 
 
MATERIALS AND METHODS: 
Materials 
Atorvastatin, Normal saline, Chloroform, Diethyl 
ether, Triton X-100, Shimadzu Electronic Balance, 
U.V spectrophotometer, Ultra homogenizer, 
Centrifuge RM-12C, Rotary Evaporator, Total 
cholesterol kits, Triglycerides Kits, HDL-Cholesterol 
Kits. 
Methods 
Cold Extraction (Methanol Extraction) 
In this work the cold extraction process was done 
with the help of methanol. About 200gms of 
powdered material was taken in a clean, flat 
bottomed glass container and soaked in 750 ml of 
methanol. The container with its contents were sealed 
and kept for period of 7 days accompanied by 
continuous shaking with the shaker. The whole 
mixture then went under a coarse filtration by a piece 
of a clean, white cotton wool. 
Evaporation of Solvent  
The filtrates (methanol extract) obtained were 
evaporated using Rotary evaporator in a porcelain 
dish. They rendered a gummy concentrate of greenish 
black. The extract was kept in vaccum dissecator for 
7 days. 
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Preliminary Phytochemical Screening  
Preliminary phytochemical screening of the 
Tephrosia purpurea extract was carried out for the 
analysis of Alkaloids, Carbohydrates, Tannins, 
Saponins, Steroids, Phenols, Flavonoids. as per the 
standard methods. 
Acute toxicity studies  
The Acute Toxicity Studies was performed using 
female rats as per OECD Guideline No.423 (Short 
term toxicity). Male mice were selected of weight 
around 50 ±10 gm for main test. Single animals are 
dosed in sequence usually at 48 h intervals. A Dose 
Progression Factor of 3.2 is used. Using the default 
dose progression factor, doses would be selected 
from the sequence (1.75, 5.5, 17.5, 55, 175, 550, 
1750, and 5000). However, the time intervals 
between dosing are determined by the onset, 
duration, and severity of toxic signs. Treatment of an 
animal at the next dose should be delayed until one is 
confident of survival of the previously dosed animal. 
If the animal survives, the second animal receives a 
higher dose. If the first animal dies or appears 
moribund, the second animal receives a lower dose. 
The toxicological effects were observed in terms of 
mortality expressed as LD50. The number of animals 
dying or surviving during a period was noted41.  
 
Method of Induction 
The systemic administration of the surfactant Triton 
X-100 to mice results in a biphasic elevation of 
plasma cholesterol and triglycerides. Hyperlipidemia 
was induced in Wistar albino mice by single 
intraperitoneal injection of freshly prepared solution 
of Triton-X-100 (100 mg/kg) in physiological saline 
solution after overnight fasting for 18 h. 
 
Experimental Animal Protocol 
Experimental mice, straved for 18 hr, were provided 
water ad libitum. The rats were divided in to six  
groups containing four animals in each group.  
Group – I     : Normal Control.(Normal saline 
10ml/kg orally for 7 days) 
Group – II   :  Hyperlipedemic control, (Triton x 
100.)  
Group – III  : Hyperlipedemic mice treated with 
METP at dose of 500mg/kg. for 7days 
Group – IV  :  Hyperlipedemic mice treated with 
PETP at dose of 400mg/kg for 7days. 
Group – V   :  Hyperlipedemic mice treated with 
PETP  at dose  of 500mg/kg. for 7days. 
Group – VI  :  Hyperlipedemic mice treated with 
Atorvostatin at 10 mg/kg for 7days. 
All the groups recives single i.p. injection of Trition 
X-100 at dose of  100mg/kg, simultaneously with 
Group- II, Group – III, Group – IV, Group – V, 
Group – VI , expect Group – I (Normal control). 
After 72 hours of Triton X-100 injection. The Group 
– VI receives Atorvostatin at dose of 10 mg/kg, was 
prepared by suspending bulk Atorvastatin in aqueous 
0.5% methyl cellulose42 for 7 days.   The Group– III, 
receive METP, at daily dose of 500mg/kg orally for 7 
days and Group – IV, Group – V receives PETP at 
daily dose of 400mg/kg and 500mg/kg orally for 7 
days . 
RESULTS AND DISCUSSION: 
Preliminary Phytochemical Screening 
Investigation revealed the presence of Alkaloid, 
Tannin, Saponin, Phenol in Methanolic Extract of 
Tephrosia purpurea  while only Phenol were present 
in Phenolic Extract of Tephrosia purpurea  
 
Table 1: Preliminary Phytochemical Screening 
 
Phytochemical Results 
Steroid + 
Alkaloid + 
Tannin + 
Carbohydrate - 
Phenol + 
Flavonoid + 
Saponin _ 
      (+) Present.                    (-) Absent  
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Table 2: Lipids Levels Obtained on 8th Day (After Treatment) 
Sl.NO GROUPS TC TG HDL LDL VLDL 
I Normal Control 64.03 ± 1.45 82.66 ± 2.46 38.91 ± 2.33 8.45 ± 3.43 16.53 ± 0.49 
II Hyperlipidemic 
Control 
192.47 ± 5.05 168.9±5.28 21.86±2.74 136.82±7.00 33.79±1.05 
III METP 500mg/kg 124.19 ± 9.5* 127.7 ± 10.5* 29.1 ± 
2.9*** 
86.8 ± 6.6* 25.5 ± 2.05*** 
IV PETP400mg/kg. 120.4 ± 9.4* 109.3 ± 6.6* 30.0 ± 3.3** 70.1 ± 
10.5*** 
22.5 ± 2.3*** 
V PETP 500mg/kg. 132.7 ±9.25* 102.5 ±9.2* 33.1 ± 3.1** 56.1 ± 5.9* 28.1 ± 1.4*** 
VI Standard 
Atorvostatin10mg/kg 
92.29 ± 5.63* 102.26 ±  
7.68* 
39.18 ± 
3.14** 
32.91 ± 
7.61* 
20.44 ± 1.53** 
All the data are expressed as MEAN ± S.D (n=4),*P = < 0.001, **P = < 0.01, ***P = < 0.05. vs GROUP .II TC: 
Total Cholesterol ; TG: Triglycerides ; HDL-C : High Density Lipoprotein cholesterol   ; LDL-C : Low Density  
Lipoprotein- cholesterol ; VLDL-C : Very Low Density Lipoprotein ; METP: Methanolic Extract of Tephrosia 
purpurea .;   PETP: Phenolic Extract of Tephrosia purpurea 
 
Fig 1: Effect of Tephrosia purpurea  Extracts on Serum Total Cholesterol levels. 
 
Fig 2: Effect of Tephrosia purpurea  Extracts on Serum Triglycerides levels. 
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Fig 3: Effect of Tephrosia purpurea  Extracts on Serum LDL-C levels. 
 
Fig 4: Effect of Tephrosia purpurea  Extracts on Serum VLDL-C levels. 
 
Fig 5:  Effect Tephrosia purpurea  on Serum HDL-C levels. 
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DISCUSSION: 
The present study was designed to investigate the 
antihyperlipidemic activity of Tephrosia purpurea  
extract in Triton X-100 induced hyperlipidemic mice. 
Phytochemical Investigation revealed the presence of 
Alkaloid, Tannin, Saponin, Phenol in Methanolic 
Extract of Tephrosia purpurea  while only Phenol 
were present in Phenolic Extract of Tephrosia 
purpurea  %Yield value of Methanolic Extract  from 
Aerial Parts of Tephrosia purpurea  was found to be 
25.7 % Yield value of Phenolic Extract from Aerial 
Parts of Tephrosia purpurea  was found to be 12.6 
%.  
Administration of Triton-X-100 (100mg/kg) to all the 
fasted rats caused an elevation of TC,TG, VLDL and 
LDL and reduction in HDL levels.  After 72 hrs of 
induction of Triton X-100 results in hyperlipidemia 
which is compared with normal control group .which 
results in significantly increased serum lipid levels in 
hyperlipidemic group. 
The change in lipid levels in group number III to VI, 
were comparable with group of Hyperlipidemic 
control ( i.e Triton X-100 ,Group- II) . The Standard 
group (i.e Atorvostatin group) significantly lowers 
the serum lipid level (P<0.001). 
The results of the study clearly indicate that METP 
Extract and PETP Extract at a dose of 500 mg/kg & 
400 mg/kg significantly lowered serum lipid levels 
(P<0.01). PETP Extract at a dose of 500 mg/kg 
significantly lowered serum lipid  levels, (P<0.001) 
i.e. antihyperlipidemic activity which was found to be 
more effective in higher dose of PETP as compared 
to METP and lower dose of PETP when administered 
orally in triton induced hyperlipidemic models. 
 
METP Extract having very low hypolipidemic 
activity. PETP Extracts showed a dose dependant 
decrease in the levels of cholesterol, Triglyceride, 
LDL-C and VLDL-C level. Among three groups (i.e. 
group number III-V), Group number- V reduced the 
elevated lipid levels more significantly than the other 
Groups.(P<0.001) 
 
Flavonoids have exhibited a variety of 
pharmacological activities, including the 
antiatherogenesis and antioxidant effect. Thus the 
present result strongly suggests that the 
hypolipidemic activity of this medicinal plant could 
be attributed to the presence of Tannis, Phenols, 
Flavonoids. in the  Extracts. 
 
CONCLUSION: 
The results concluded that PETP (500 mg/kg) have 
definite antihyperlipidemic activity in Triton X-100 
induced hyperlipidemic model and which is 
equipotent activity when compared with Atorvastatin 
treated groups. Further studies on this extract may 
lead to identify the possible mechanism of action and 
isolation of active principle from the same. 
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